biosectinvestor
6 minutes ago
It relates to DCVax-L. UCLA and NWBO have a co-development relationship and UCLA can study and even develop new modes of use, like combination therapies. This is quite common with new treatments, especially biologics. The relationship will typically have codevelopment IP, like the combination therap